Breaking news
Australian Open: Gaël Monfils continues -
Makhachev safely defeats Tsarukyan at UFC 311. -
Moissac. An evening full of nostalgia at the Paris hall -
Wall. Conference: Raymond Lafage, “Occitan Caravaggio” -
La Clé des chants has its cabaret -

Araujo stays, but another defender closes in on Manchester United

Araujo stays, but another defender closes in on Manchester United
Araujo stays, but another defender closes in on Manchester United

At FC Barcelona, ​​this month of January was very lively between the file of the registration of Dani Olmo and Victor, the victory Sunday evening in the final of the Spanish Super Cup 5-2 against Real Madrid and finally the thorny management of the Ronald Araujo case. While he wanted to leave the club, Deco managed to convince him to stay and even extend according to information from Jijantes journalist Gerard Romero. But at the same time, another defender in the squad would be getting closer to a departure for the Premier League.

Christensen tracked by Manchester United

Injured since August 23 after a ruptured Achilles tendon, Andreas Christensen should make his return on Saturday against Getafe. But internally, Sport reveals that the sports management would have been approached by Manchester United for a possible transfer of the Danish defender at the end of his contract in 2026. Arriving in 2022, Christensen had established himself as a real boss of the Barcelona rearguard. But his physical fragility and the almost complete arrival of Jonathan Tah this summer could lead to a sale and also free up payroll.

Also read:

Barça: a return of weight looms for Flick

Barça: the resounding bombshell is confirmed for Araujo

Featured Podcasts

MEN LIFE

To summarize

While Ronald Araujo should ultimately stay at FC Barcelona, ​​another defender in the squad is approaching Manchester United. The English club have approached Barça in recent weeks to discuss a transfer of Andreas Christensen.


Senegal

-

-

PREV Spain.. Arrest of a Seville club player for a “betting” affair
NEXT Short opioid interviews: now is the time to get started